Prasugrel (Panacea Biotec Ltd.)
Welcome to the PulseAid listing for the Prasugrel drug offered from Panacea Biotec Ltd.. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Panacea Biotec Ltd. |
NON-PROPRIETARY NAME: | Prasugrel |
SUBSTANCE NAME: | PRASUGREL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-16 |
END MARKETING DATE: | 0000-00-00 |
Prasugrel HUMAN PRESCRIPTION DRUG Details:
Item Description | Prasugrel from Panacea Biotec Ltd. |
LABELER NAME: | Panacea Biotec Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-10-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43817-239_939dce06-52a2-3b91-7ec6-8ce281d5ddda |
PRODUCT NDC: | 43817-239 |
APPLICATION NUMBER: | ANDA205897 |
Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: